Pfizer, a publicly owned company headquartered in the United States, was founded in 1849, employs approximately 100,900 individuals, and reported $62.6B in revenue as of 2025. The company specializes in pharmaceutical manufacturing.
On September 11, 2026, Pfizer transferred the Minipres and Minipress hypertension trademarks in India to Novartis India, marking its exit from a legacy cardiovascular brand in that market. This deal provides Novartis India with added scale in blood pressure treatments. Earlier, on September 10, Novavax highlighted Pfizer as a key commercial and development partner for its Matrix-M platform, as Novavax pivots toward a partnership-driven model after moving beyond its COVID-19 vaccine focus. Also on September 10, Medicus Pharma secured an agreement with Pfizer, which strengthens Medicus Pharma's position in precision oncology and provides resources to advance its lead cancer program.
Subscribe for full access to Pfizer's products in full detail
Subscribe for full access to Pfizer's revenue in full detail
Subscribe for full access to Pfizer's products in full detail 
